Displaying 11 - 15 of 50
Tue 18 October 2016
A new treatment licensed for advanced pancreatic cancer could potentially provide second option for patients for whom chemotherapy not effective.Read More about 'New licensed treatment could mean people live for longer'
Thu 07 July 2016
We welcome the publication of the Government's response to an independent review of choice in end of life care.Read More about 'We welcome Government’s proposals to improve end of life care'
Sat 11 June 2016
Latest UK data shows that pancreatic cancer patients are missing out on clinical trials as part of their treatment – with less than 5% taking part in pancreatic cancer trials.Read More about 'Hundreds of patients missing out on UK trials'
Wed 18 May 2016
NICE has annouced that it has brought forward a reappraisal of chemotherapy drug Abraxane for patients with secondary (advanced) pancreatic cancer in England.Read More about 'NICE announces Abraxane reappraisal'
Mon 16 May 2016
We are one of fifteen signatories to an open letter to the Prime Minister - calling on the government to change the methods used to appraise drugs by NICE.Read More about 'Joint open letter to the Prime Minister on Cancer Drugs Fund'